MDS Virtual Congress 2021 Archives - Page 128 of 132

Machine Learning (ML) Prediction of Parkinson’s Disease (PD) Risk and Nigral Neuron Density

I. Karabayir, L. Butler, S. Goldman, R. Kamaleswaran, F. Gunturkun, R. Davis, GW. Ross, H. Petrovitch, K. Masaki, C. Tanner, G. Tsivgoulis, A. Alexandrov, O. Akbilgic (Maywood, USA)
Maintenance of physical activity (PA) mitigates worsening of patient-reported outcomes in Parkinson’s disease (PD) during the COVID-19 pandemic

J. Morley, I. Subramanian, J. Farahnik, L. Mischley (Philadelphia, USA)
Management of tremor secondary to MORC2 related neurodevelopmental disorder with deep brain stimulation

M. Hull, D. Curry, M. Parnes (Houston, USA)
Mapping intrinsically photosensitive retinal ganglion cells (ipRGCs) dysfunction in patients with Parkinson disease using Chromatic pupilloperimetry

T. Fay-Karmon, D. Jaber, I. Sher, S. Zorani, A. Bleterman, Y. Rotenstreich, S. Hassin-Baer (Ramat Gan, Israel)
Mapping regional alpha-synuclein seeding capacity in Multiple System Atrophy

I. Martinez-Valbuena, N. P. Visanji, A. Kim, S. Lee, S. Alshimemeri, R. So, A. Gao, J. C. Watts, A. Lang, G. G. Kovacs (Toronto, Canada)
MAPT mutation frontotemporal dementia with parkinsonism: when previous results can skew the diagnosis

R. Franco, TC. Aguiar, A. Morganho, P. Lobo, R. Dias, S. Aguiar (Funchal, Portugal)
Markers of Parkinson-related impulsive-compulsive behaviors in the activity of single units in the subthalamic nucleus

M. Vissani, F. Micheli, G. Pecchioli, S. Ramat, A. Mazzoni (Pontedera, Italy)
Maximising UPDRS information while minimising assessment time

G. Morinan, J. Tang, J. O'Keeffe (London, United Kingdom)
MDS Basic Scientists Survey demonstrates Potential for Crosspollination between Basic Scientists and MDS

B. Bergmans, H. Tibar, M. Carecchio, S. Ibrahim El-Jafaary, M. Matarazzo, S. Perez-Lloret, R. Rajan, T. Cardoso Vale, N. Vijaratnam, T. Riestra, M. Fabbri, B. Bloem (Bruges & Ghent, Belgium)
MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS

S. Luo, N. Lapelle, P. Martin, S. Ali, C. Goetz, G. Stebbins (Durham, USA)
MDSGene systematic review on dopa-responsive dystonia caused by mutations in GCH1, TH, SPR, PTS, or QDPR

A. Weissbach, R. Herzog, M. Pauly, L. Hahn, I. König, S. Camargos, B. Jeon, M. Kurian, T. Opladen, N. Brüggemann, C. Klein, K. Lohmann (Lübeck, Germany)
Measures of Physical Activity in Parkinson’s Disease (MAPD)

J. Gilby, C. Carroll, J. Marsden (Plymouth, United Kingdom)
Measuring progression of Parkinson’s disease cardinal signs in the Phase 2 SPARK study

KP. Kilambi, T. Dam, J. Edgerton, T. Fox, S. Khan, J. Xiao, M. Yang, P. Bergethon (Cambridge, USA)
Medically refractory Graves’ disease presenting as chorea and carbohydrate hyperphagia in a Kenyan adolescent

N. Mongare, E. Njenga, D. Sokhi (Nairobi, Kenya)
Medication effects and validity of home-based freezing tests in Parkinson’s disease

D. Zoetewei, P. Ginis, T. Herman, D. Denk, M. Brozgol, P. Thumm, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)
Metabolic activity and perfusion of basal ganglia in patients with hemichorea and carotid stenosis

Z. Drakulić, P. Tomše, E. Rebec, J. Jamšek, J. Pretnar Oblak, P. Miklavčič, M. Trošt, M. Kojović (Ljubljana, Slovenia)
Metabolic alterations in a Drosophila model of Parkinson’s disease

C. Solana-Manrique, F J. Sanz, I. Torregrosa, N. Paricio (Burjassot, Spain)
Metabolic patterns and neurodegeneration in isolated REM sleep behavior disorder

JH. Shin, JY. Lee, YK. Kim, HJ. Kim, EJ. Yoon, HW. Nam, B. Jeon (Seoul, Republic of Korea)
Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease (PD)

D. Hill, D. Stephenson, J. Brayanov, K. Claes, R. Badawy, S. Sardar, K. Fisher, S. Lee, A. Bannon, V. Terebaite, R. Bhatnagar (St Pierre Dechartreuse, France)
Methods for addressing missing covariate data in left truncated samples with application to Parkinson’s disease research

H. Richardson, S. Xie (Philadelphia, USA)
Methylation status of SNCA gene in multiple system atrophy and Parkinson’s disease

E. Iakovenko, N. Abramycheva, E. Fedotova, S. Illarioshkin (Moscow, Russian Federation)
MICROBIAL TRANSLOCATION IN PATIENTS WITH PARKINSON DISEASE AT THE UNIVERSITY TEACHING HOSPITAL, LUSAKA, ZAMBIA: A CASE CONTROL STUDY

L. Chishimba, E. Sinkala, P. Kelly, M. Atadzhanov (Lusaka, Zambia)
MicroRNAs as a potential biomarker of Parkinson’s disease

N. Ardashirova, A. Protopopova, N. Abramycheva, E. Fedotova, S. Illarioshkin (Moscow, Russian Federation)
Mild cognitive impairment does not predict development of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson’s disease

SF. Fjeldhøj, BLC. Thomsen, PMP. Pedersen, SRJ. Jensen, MK. Karlsborg, AL. Løkkegaard (Copenhagen, Denmark)
Mild parkinsonian signs in older adults correlate with an impaired functional level – a cross-sectional general population study from the “Good Aging in Skåne” cohort

C. Algotsson, A. Rosso, S. Elmståhl, A. Siennicki-Lantz (Malmö, Sweden)
Minimum detectable change of an automated algorithm derived spiral analysis parameter

R. R (Ansarinagar, India)
Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease

M. Nikitina, A. Bragin, E. Bragina, V. Alifirova, N. Zhukova, D. Gomboeva, V. Spitsyn (Tomsk, Russian Federation)
Model Innovation in Parkinson’s disease drug development: linking Quantitative Systems Pharmacology to the patient voice

J. Barrett, B. Piccoli, M. Muller, K. Barrett, D. Goncharov, C. Kaddi, K. Azer, K. Romero, D. Stephenson (Tucson, USA)
Modeling of the Placebo Response in Parkinson’s Disease

S. Branders, O. Rascol, G. Garraux, B. Berman, G. Stebbins, C. Goetz, C. Billocq, A. Pereira (Mont-Saint-Guibert, Belgium)
Molecular changes of a de novo missense variant in VPS16 in dystonia

H. Pott, K. Zeuner, C. örün, S. Paschen, S. Diaw, K. Plötze-Martin, M. Borsche, G. Kuhlenbäumer, C. Klein, N. Brüggemann, M. Klinger, K. Lohmann (Lübeck, Germany)
Molecular investigation of apparently healthy heterozygous Parkin mutation carriers

M. Castelo, A. Zanon, V. Gilmozzi, C. Klein, P. Pramstaller, A. Hicks, I. Pichler (Bolzano, Italy)
MOLECULAR-GENETIC ASPECTS OF WILSON’S DISEASE IN UKRAINE

I. Voloshyn-Haponov (Kharkiv, Ukraine)
Monitoring electrophysiological parameters in PD patients enrolled for MRgFUS: l’Aquila-tor Vergata experience

R. Cerroni, P. Sucapane, M. Conti, D. Cerone, C. Liguori, A. Stefani, C. Marini (Rome, Italy)
Monogenic Hub of the Global Parkinson’s Genetics Program (GP2): The 500-genomes pilot project

L. Lange, K. Lohmann, EM. Valente, SY. Lim, AH. Tan, EJ. Vollstedt, M. Avenali, H. Madoev, P. Heutink, K. Kumar, N. Mencacci, C. Klein (Luebeck, Germany)
Monogenic Portal of the Global Parkinson’s Genetics Program (GP2)

SY. Lim, LM. Lange, H. Madoev, KR. Kumar, AH. Tan, M. Avenali, P. Heutink, EJ. Vollstedt, K. Lohmann, N. Mencacci, C. Klein, EM. Valente (Kuala Lumpur, Malaysia)
Mood is a Key Factor in Progression of Non-Motor Symptoms Burden in Parkinson´s disease.

D. Santos García, C. Cores, T. de Deus, J. Paz González, C. Martínez, E. Suárez, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, M. Catalán, V. Nogueira, V. Puente, J. García Moreno, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, C. Ordás, L. López Díaz, P. Mir, P. Martínez Martín, C. Coppadis (A Coruña, Spain)
Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area

R. Patel, G. Stebbins, B. Barton (Chicago, USA)
Mortality of people with Parkinson’s disease in a large population-based cohort study. Time trends and relationship to disease progression.

O. Okunoye, L. Horsfall, L. Marston, K. Walters, A. Schrag (London, United Kingdom)
Motor and non-motor effects of mevidalen in Lewy Body Dementia as measured by the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

K. Biglan, L. Munsie, K. Svensson, P. Ardayfio, M. Pugh, J. Sims, M. Brys (Indianapolis, USA)
Motor cerebro-cerebellar networks breakdown among different subtypes of Parkinson’s disease

S. Basaia, F. Agosta, A. Francia, C. Cividini, T. Stojkovic, I. Stankovic, R. de Micco, L. Albano, E. Sarasso, A. Gardoni, N. Piramide, V. Markovic, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)
Motor evaluation of Parkinson’s disease patients through video consultations in the Brazilian public health system – a real life feasibility study

D. Dos Santos, D. Camelo, M. Strelow, M. Silva, P. Führ, L. Marins, A. Schumacher-Schuh (Porto Alegre, Brazil)
Motor Function Test Protocol for Parkinsonian Triad in Rodent Model of Parkinson’s Disease

M. Sirajo, K. Murtala, J. Oyem, O. Ishola, O. Lukman (Kano, Nigeria)
Motor skills of walking in Parkinson’s disease: towards a better understanding of the cognitive abilities implicated in F8WT.

V. Cian, M. Zarucchi, C. Siri, A. Giobbia, P. Ortelli, G. Frazzitta, M. Canesi (Gravedona Ed Uniti, Italy)
Motor symptom lateralization influences cortico-striatal functional connectivity in Parkinson’s disease

W. Su, K. Li, C. Li, X. Ma, H. Zhao, M. Chen, S. Li, R. Wang, B. Lou, H. Chen, C. Yan (Jinan, China)
Motor-cognitive interference during touchscreen manipulations in Parkinson’s disease

J. de Vleeschhauwer, S. Broeder, P. Ginis, L. Janssens, A. Nieuwboer, E. Nackaerts (Leuven, Belgium)
Movement Disorder Fellowships: Assessment and Recruitment Strategies to Meet Clinical Needs

M. Rashid, A. Zafar, J. Owens, G. Patino, M. Robbins, S. Sandrone, H. Sarva (Ottawa Hills, USA)
MOVEMENT DISORDERS IN CHILDREN WITH ATP1A3 GENE MUTATIONS. A SERIES OF CHILEAN PATIENTS

M. Troncoso, D. Munoz, V. Naranjo, M. Matamala, J. Tello, S. Witting, A. Barrios, M. Hidalgo, I. Ruiz (Santiago, Chile)
Movement disorders in demyelination: A case series of ten patients

R. Singh, S. Pandey (New Delhi, India)
Movement Disorders in Subacute Sclerosing Panencephalitis Patients

C. Rawat, S. Pandey (New Delhi, India)
Movement vigor is differentially encoded in motor cortex and globus pallidus in Parkinson disease

K. Cross, E. Koenig, J. Choi, N. Pouratian (Los Angeles, USA)
Movement-related dynamics of β-γ phase-amplitude coupling in repetitive movement tasks of Parkinson disease

R. Gong, T. Knösche, J. Classen (Leipzig, Germany)
MR guided high-intensity ultrasound thalamotomy in essential tremor and Parkinson´s disease: is there an ideal candidate?

I. Aviles-Olmos, A. Martín-Bastida, A. Gorospe-Osinalde, J. Carte-García, P. Manrique, A. Arcadi, O. Parras, M. Fernández-Martínez, L. Armengou-García, L. González-Quarante, J. Guridi, MC. Rodríguez-Oroz (Pamplona, Spain)
MRgFUS Pallidothalamic Tractotomy for axial symptoms in Parkinson’s disease in 4 consecutive patients: single center experience

W. Lin, WC. Chang (Changhua, Taiwan)
Multifractal spectrum width of pallidal activity correlates with dystonic severity

U. Semenova, V. Popov, R. Medvednik, A. Tomskiy, A. Sedov (Moscow, Russian Federation)
Multimodal Conversational AI for Remote Patient Monitoring and Analysis of Parkinson’s Disease

V. Ramanarayanan, A. Exner, D. Pautler, S. Snyder, H. Kothare, J. Liscombe, D. Suendermann-Oeft, A. Lambert, R. Kohlmeier, J. Huber (San Francisco, USA)
Multimodal, longitudinal investigation in Dopa-responsive dystonia

A. Steinmeier, MG. Pauly, DM. Al-Shorafat, G. Saranza, AE. Lang, N. Brüggemann, V. Tadic, C. Klein, K. Lohmann, MJN. Brown, C. Beste, A. Münchau, T. Bäumer, A. Weissbach (Lübeck, Germany)
Mutation analysis of BSN gene in patients with multiple system atrophy

M. Wakita, A. Nagai, H. Yaguchi, I. Yabe (Sapporo, Japan)
Mutations in GBA and LRRK2 are not associated with increased inflammatory markers

A. Thaler, N. Omer, N. Giladi, T. Gurevich, A. Bar Shira, O. Goldstein, M. Gana-Weisz, M. Kestenbaum, J. Shirvan, J. Cedarbaum, A. Orr-Urtreger, S. Shenhar-Tsarfaty, A. Mirelman (Tel-Aviv, Israel)
My hands are shaking : A Tunisian cohort study

M. Akkari, S. Zakaria, M. Zouari (Tunis, Tunisia)
Myoclonus, Tremor, and Ataxia After COVID-19 Infection

B. Dorfman, W. Tse (New York, USA)